NYSE ARCA | ETF
The fund employs an indexing investment approach designed to track the performance of the index, an index made up of stocks of large, mid-size, and smallU. S. companies within the health care sector, as classified under the GICS.
The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 13.12% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.15% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.67% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.26% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.99% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.32% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.31% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.08% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.67% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.31% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.24% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.15% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.14% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 1.87% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.84% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.76% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.67% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 1.55% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 1.53% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.22% |